Yahoo Web Search

  1. Ads
  1. US STOCKS-Wall Street dips as focus shifts to Fed

    Reuters via Yahoo FinanceOct 30 14:22 PM

    Shares of tech heavyweights Apple Inc and Facebook Inc also fell marginally ahead of their earnings reports after markets close.

  2. Altria takes a $4.5 billion hit on Juul amid vaping backlash

    Associated Press via Yahoo FinanceOct 31 22:13 PM

    Since last year, Juul has been hit by new federal and state investigations into its marketing amid an explosion of underage vaping among teenagers.

  3. Analysts Bullish on Axonics' Prospects via Yahoo FinanceNov 04 21:33 PM

    (NASDAQ:AXNX) recently received Food and Drug Administration approval for its implantable, rechargeable sacral neuromodulation (SNM) system to treat fecal incontinence ...

  4. The U.S. Food and Drug Administration on Monday classified the recall of Abbott Laboratories' CentriMag blood pumping system following the death of ...

  5. One focus of the FDA's work over the past year has been implementing the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities ...

  6. New Juul CEO reshuffles top deck to fix image

    Reuters via Yahoo FinanceOct 29 18:14 PM

    The departures of Chief Financial Officer Tim Danaher and Chief Marketing Officer Craig Brommers come just weeks after Juul suspended advertising in the United States.

  7. US STOCKS-Stocks little changed in wake of Fed statement

    Reuters via Yahoo FinanceOct 30 18:36 PM

    The Fed cut lowered its policy rate to a target range between 1.50% and 1.75%, but dropped a previous reference in its statement to "act as appropriate" to support the economic expansion ...

  8. 5 'Strong Buy' Biotech Stocks With Rapidly Approaching Catalysts

    Kiplinger via Yahoo FinanceOct 24 19:57 PM

    Here are five biotech stocks that have a "Strong Buy" consensus analyst rating and have potential catalysts right around the corner. Acceleron Pharma (XLRN, $42.50) uses TGF-beta proteins ...

  9. SILVER SPRING, Md., Nov. 8, 2019 /PRNewswire/ -- Today the U.S. Food and Drug Administration granted approval to Reblozyl (luspatercept–aamt) for the ...

  10. Ex-Theranos President Must Reveal Portfolio, Net Worth to SEC

    Bloomberg via Yahoo FinanceNov 06 23:42 PM

    “There’s a criminal charge in this set of cases,” Cousins said as part of his decision allowing Balwani to interview a high-level official at the U.S. Food and Drug ...

  1. Ads